About Demiurge Technologies
Demiurge Technologies is a Healthcare company based in Zug (Switzerland) founded in 2015. It operates as a developer of neural network models and neuromorphic chips. Demiurge Technologies has raised $9.5 million across 2 funding rounds from investors including Lun Feng and Hongdao. Demiurge Technologies offers products and services including Virtual Patients Platform. Its focus areas include HealthTech, Life Sciences Tech, Research & Development and Clinical Trials. Its legal entity is Demiurge Technologies AG. Its competitors include Unlearn, Virtonomy, ELEM Biotech, Akkure and adsilico and 3 more; 6 of its 8 listed competitors have raised funding.
Company details
Demiurge Technologies was founded in 2015 and is based in Zug, Switzerland. Operations focus on the artificial intelligence sector, where neural network models and neuromorphic chips inspired by consciousness are created. Artificial intelligence design services are provided for neuromorphic chips and biomorphic robots, utilizing a novel spiking neural network model. The company addresses advancements in neuromorphic computing and related robotics applications.
- Headquarters Zug, Switzerland
- SectorsHealthcare
- Website demiurge.technology
- Social LinkedIn
- Legal Name Demiurge Technologies Ag
- Total Equity Funding$9.5M (USD)
in 2 rounds
- Latest Funding Round$7.7M (USD), Series A
Dec 2015
- InvestorsHongdao
& 1 more
Products & Services of Demiurge Technologies
Demiurge Technologies offers a comprehensive portfolio of products and services, including Virtual Patients Platform.
Simulates human patients to predict clinical trial outcomes accurately.
Funding Insights of Demiurge Technologies
Demiurge Technologies has successfully raised a total of $9.5M across 2 strategic funding rounds. The most recent funding activity was a Series A round of $7.7 million completed in December 2015. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $9.5M
- Total Rounds 2
- Last Round Series A — $7.7M
- First Round $1.8M
(Dec 2015)
- Investors Count 2
All 2 funding rounds of Demiurge Technologies with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
2 investors in total: 1 institutional and 1 angel.
Investors in Demiurge Technologies
Demiurge Technologies has secured backing from 2 investors, including angel and institutional investors. Prominent investors backing the company include Lun Feng and Hongdao.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
- | – | hongdao.hnfun.com | - | |
LF Lun Feng | - | – | unknown_3578a46191814c14b | - |
Investor details for Demiurge Technologies
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Demiurge Technologies
2 people are tracked at Demiurge Technologies (2 in leadership).
| Name | Role | Group |
|---|---|---|
Idonae Lovetrue | Chief Executive Officer | Leadership |
Bragi Lovetrue | CTO | Leadership |
Complete people profiles for Demiurge Technologies
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of Demiurge Technologies
2 dated milestones of Demiurge Technologies, from founding to its latest funding, stage changes and deals.
- Founded Demiurge Technologies is founded.
- Funding First funding round of $1.8M.
Competitors of Demiurge Technologies
Demiurge Technologies has 8 listed competitors in our database, 6 of them funded. They include Unlearn, Virtonomy, ELEM Biotech, Akkure and adsilico, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| unlearn.ai | 2017 | San Francisco, United States | $127.13M | – | Provider of AI-based clinical trial management software | |
| virtonomy.io | 2019 | Munich, Germany | $3.82M | – | Virtual patient simulations are provided for medical device development. | |
| elem.bio | 2018 | Barcelona, Spain | $2.27M | – | A simulation-based platform for virtual medical trials is provided. | |
| akkure.com | 2016 | Dublin, Ireland | $3.37M | – | Blockchain-based platform for genomic data analytics is provided. | |
| adsilico.uk | 2022 | London, United Kingdom | $4.56M | – | In-silico trial solutions for medical device testing are developed. | |
| electrictwin.com | 2020 | London, United Kingdom | $13.02M | – | AI-powered digital twin technology for research and clinical applications in the life sciences industry | |
| exoralabs.com | 2019 | Bengaluru, India | – | – | AI platform for healthcare summaries, data management, and insights optimization. | |
| hakobio.com | 2014 | Brussels, Belgium | – | – | Digital twin creation for biopharma facilities, simulation, training, and asset management. |
Detailed competitors of Demiurge Technologies
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Demiurge Technologies
The website of Demiurge Technologies (demiurge.technology) receives about 1.8K visits a month.
- Monthly visits1.8K
▲ 134.2% vs previous month
Top companies in Life Sciences Platforms & Tools
10 companies that operate in the same segment as Demiurge Technologies (Life Sciences Platforms & Tools), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Medidata is recognized as a leading provider of SaaS solutions for clinical research. | 1999 | New York, New York, United States | USD 41.5 M | – | – | |
AI-based solutions for health management are provided. | 2015 | Dallas, Texas, United States | USD 2.8 B | – | – | |
Nanopore-based electronic systems for single-molecule analysis are developed. | 2005 | Oxford, Oxfordshire, United Kingdom | USD 1.3 B | USD 301.49 M | 1,480 | |
Real-world health data is provided for research and decisions. | 2012 | Menlo Park, California, United States | USD 259.16 M | – | – | |
Genetically modified cell lines are developed using AAV gene-editing platform. | 2007 | Cambridge, Cambridgeshire, United Kingdom | USD 46.29 M | – | – | |
Biological reagents and antibodies are developed for life science research. | 1998 | Cambridge, Cambridgeshire, United Kingdom | USD 78.8 M | – | – | |
Electron microscopy services and microanalysis instruments are provided. | 1956 | Waltham, Massachusetts, United States | – | USD 44.56 B | 125,000 | |
Novel therapeutics are discovered using an AI-enabled drug platform. | 2013 | New York, New York, United States | USD 456.66 M | USD 74.68 M | – | |
A platform for sharing and accessing academic research papers is provided. | 2008 | San Francisco, California, United States | USD 58.4 M | – | – | |
Developer of molecular diagnostic testing solutions | 1996 | Sunnyvale, California, United States | USD 19.1 M | USD 54.88 M | 208 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Demiurge Technologies
Demiurge Technologies was founded in 2015.
Demiurge Technologies is headquartered in Zug, Switzerland. It is registered at Zug, Zug, Switzerland.
Demiurge Technologies is a funded company, having raised a total of $9.5M across 2 funding rounds to date. The company's 1st funding round was a Angel Round of $1.8M, raised on Dec 2015.
Demiurge Technologies was founded in 2015 and is based in Zug, Switzerland. Operations focus on the artificial intelligence sector, where neural network models and neuromorphic chips inspired by consciousness are created. Artificial intelligence design services are provided for neuromorphic chips and biomorphic robots, utilizing a novel spiking neural network model. The company addresses advancements in neuromorphic computing and related robotics applications.
Demiurge Technologies's top competitors include Unlearn, Virtonomy and ELEM Biotech.
Demiurge Technologies offers Virtual Patients Platform.
Demiurge Technologies has 2 investors. Key investors include Lun Feng, and Hongdao.
Demiurge Technologies operates through Demiurge Technologies Ag.